These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 3187441)

  • 1. A pilot study of metabolic effects of intravenously given alpha-calcidol in patients with chronic renal failure.
    Lind L; Lithell H; Wengle B; Wrege U; Ljunghall S
    Scand J Urol Nephrol; 1988; 22(3):219-22. PubMed ID: 3187441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Pilot Study of Metabolic Effects of Intravenously Given Alpha-Calcidol In Patients With Chronicc Renal Failure.
    Lind L; Lithell H; Wenglc B; Wrege U; Ljunghall S
    Scand J Urol Nephrol; 1988 Jan; 22(3):219-22. PubMed ID: 27031881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperparathyroidism, glucose tolerance and platelet intracellular free calcium in chronic renal failure.
    Lu KC; Shieh SD; Lin SH; Chyr SH; Lin YF; Diang LK; Li BL; Sheu WH; Ding YA
    Q J Med; 1994 Jun; 87(6):359-65. PubMed ID: 8041868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of parathyroid function in patients with a short history of hemodialysis.
    Nishi H; Sato T; Kurihara T; Kurosawa T; Fukagawa M
    Ther Apher Dial; 2005 Feb; 9(1):39-43. PubMed ID: 15828904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte PC-1 activity in patients on maintenance haemodialysis treated with human erythropoietin and 1-alpha-D3.
    Stefanovic V; Djordjevic V; Ivic M; Mitic-Zlatkovic M; Vlahovic P
    Ann Clin Biochem; 2005 Jan; 42(Pt 1):55-60. PubMed ID: 15802034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous alfacalcidol improves insulin resistance in hemodialysis patients.
    Günal AI; Celiker H; Celebi H; Ustündağ B; Günal SY
    Clin Nephrol; 1997 Aug; 48(2):109-13. PubMed ID: 9285148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study.
    Mahfoud F; Schlaich M; Kindermann I; Ukena C; Cremers B; Brandt MC; Hoppe UC; Vonend O; Rump LC; Sobotka PA; Krum H; Esler M; Böhm M
    Circulation; 2011 May; 123(18):1940-6. PubMed ID: 21518978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent or daily administration of 1-alpha calcidol for nephrectomised infants on peritoneal dialysis?
    Saarinen TT; Arikoski P; Holmberg C; Rönnholm K
    Pediatr Nephrol; 2007 Nov; 22(11):1931-8. PubMed ID: 17851700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with one-alpha-hydroxycholecalciferol in middle-aged men with impaired glucose tolerance--a prospective randomized double-blind study.
    Ljunghall S; Lind L; Lithell H; Skarfors E; Selinus I; Sørensen OH; Wide L
    Acta Med Scand; 1987; 222(4):361-7. PubMed ID: 3321925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oral calcitriol pulse therapy on the lipid, calcium, and glucose homeostasis of hemodialysis-patients: its safety in a combination with oral calcium carbonate.
    Khajehdehi P; Taheri S
    J Ren Nutr; 2003 Apr; 13(2):78-83. PubMed ID: 12671829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose alfacalcidol controls secondary hyperparathyroidism in predialysis chronic kidney disease.
    Reichel H
    Nephron Clin Pract; 2010; 114(4):c268-76. PubMed ID: 20090369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of blood pressure by treatment with alphacalcidol. A double-blind, placebo-controlled study in subjects with impaired glucose tolerance.
    Lind L; Lithell H; Skarfors E; Wide L; Ljunghall S
    Acta Med Scand; 1988; 223(3):211-7. PubMed ID: 3281411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of alphacalcidol on calcium and phosphate metabolism in patients treated with hemodialysis].
    Veljković S; Raicević R; Cukaranović R; Ralenković S; Stojanović M; Kostić S; Djordjević V; Radenković M
    Srp Arh Celok Lek; 1996; 124 Suppl 1():117-8. PubMed ID: 9102869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised clinical study of alfacalcidol and paricalcitol.
    Hansen D
    Dan Med J; 2012 Feb; 59(2):B4400. PubMed ID: 22293059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 24R,25-dihydroxyvitamin D3 in combination with 1 alpha-hydroxyvitamin D3 in predialysis renal insufficiency: biochemistry and histomorphometry of cancellous bone.
    Birkenhäger-Frenkel DH; Pols HA; Zeelenberg J; Eijgelsheim JJ; Schot R; Nigg AL; Weimar W; Mulder PG; Birkenhäger JC
    J Bone Miner Res; 1995 Feb; 10(2):197-204. PubMed ID: 7754799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of severe secondary hyperparathyroidism in dialysis patients by intravenous 1 alpha(OH) vitamin D3, oral CaCO3 and low dialysate calcium.
    Moriniere P; el Esper N; Viron B; Judith D; Bourgeon B; Farquet C; Gheerbrant J; Chapuy M; Van Orshoven A; Pamphile R
    Kidney Int Suppl; 1993 Jun; 41():S121-4. PubMed ID: 8320904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors and risk for mortality of mild hypoparathyroidism in hemodialysis patients.
    Guh JY; Chen HC; Chuang HY; Huang SC; Chien LC; Lai YH
    Am J Kidney Dis; 2002 Jun; 39(6):1245-54. PubMed ID: 12046038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: a randomized, crossover trial.
    Moe S; Wazny LD; Martin JE
    Can J Clin Pharmacol; 2008; 15(1):e36-43. PubMed ID: 18192704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.